Related references
Note: Only part of the references are listed.Discovering dominant tumor immune archetypes in a pan-cancer census
Alexis J. Combes et al.
CELL (2022)
A four immune-related long noncoding RNAs signature as predictors for cervical cancer
Min Xu et al.
HUMAN CELL (2022)
Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
Monireh Mohsenzadegan et al.
SCIENTIFIC REPORTS (2022)
Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis
Song-Tao Xue et al.
MOLECULAR CANCER (2022)
Benchmarking joint multi-omics dimensionality reduction approaches for the study of cancer
Laura Cantini et al.
NATURE COMMUNICATIONS (2021)
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Deborah Blythe Doroshow et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
Ben M. Eyck et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Yelena Y. Janjigian et al.
LANCET (2021)
IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
Dongqiang Zeng et al.
FRONTIERS IN IMMUNOLOGY (2021)
Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway
Chao Wang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Construction of a Glycolysis-related long noncoding RNA signature for predicting survival in endometrial cancer
Yuan Jiang et al.
JOURNAL OF CANCER (2021)
Construction of Biocompatible Dual-Drug Loaded Complicated Nanoparticles for in vivo Improvement of Synergistic Chemotherapy in Esophageal Cancer
Wenhua Zhan et al.
FRONTIERS IN ONCOLOGY (2020)
Long-Noncoding RNA CASC9 Promotes Progression of Non-Small Cell Lung Cancer by Promoting the Expression of CDC6 Through Binding to HuR
Xudong Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
MOVICS: an R package for multi-omics integration and visualization in cancer subtyping
Xiaofan Lu et al.
BIOINFORMATICS (2020)
Atypical chemokine receptors in tumor cell growth and metastasis
Bal L. Lokeshwar et al.
GPCR SIGNALING IN CANCER (2020)
Benchmarking of cell type deconvolution pipelines for transcriptomics data
Francisco Avila Cobos et al.
NATURE COMMUNICATIONS (2020)
Advances in targeted therapy for esophageal cancer
Yan-Ming Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid-polymer hybrid nanoparticles
Qingxia Fu et al.
DRUG DELIVERY (2020)
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer
Yung-Jue Bang et al.
FUTURE ONCOLOGY (2019)
Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase III KEYNOTE-)181 study.
Takashi Kojima et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The emerging role of immunotherapy for esophageal cancer
Ronan J. Kelly
CURRENT OPINION IN GASTROENTEROLOGY (2019)
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer
Megan Greally et al.
CLINICAL CANCER RESEARCH (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
The immune landscape of esophageal cancer
Tu-Xiong Huang et al.
CANCER COMMUNICATIONS (2019)
Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients
Yu Imamura et al.
DIGESTION (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
High TNFAIP6 level is associated with poor prognosis of urothelial carcinomas
Ti-Chun Chan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus The Phase 2 KEYNOTE-180 Study
Manish A. Shah et al.
JAMA ONCOLOGY (2019)
Radiotherapy for esophageal carcinoma: dose, response and survival
Yijun Luo et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Esophageal cancer: Risk factors, genetic association, and treatment
Fang-Liang Huang et al.
ASIAN JOURNAL OF SURGERY (2018)
Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037
Judith Offman et al.
BRITISH JOURNAL OF CANCER (2018)
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
Yang Liu et al.
CANCER CELL (2018)
Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma
Toshihiko Doi et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts et al.
NATURE MEDICINE (2018)
Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma
Md Sazzad Hassan et al.
TRANSLATIONAL ONCOLOGY (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers
Rhonda J. Staversky et al.
SCIENTIFIC REPORTS (2018)
Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response
Bryan J. Schneider et al.
CLINICAL CANCER RESEARCH (2017)
The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma
Gianmarco Contino et al.
GASTROENTEROLOGY (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data
Julien Racle et al.
ELIFE (2017)
Oesophageal cancer
Elizabeth C. Smyth et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm
Prabhakar Chalise et al.
PLOS ONE (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Tumor microenvironment and therapeutic response
Ting Wu et al.
CANCER LETTERS (2017)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
The MAGE protein family and cancer
Jenny L. Weon et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines
Paul Geeleher et al.
GENOME BIOLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Tom Waddell et al.
LANCET ONCOLOGY (2013)
The quest to overcome resistance to EGFR-targeted therapies in cancer
Curtis R. Chong et al.
NATURE MEDICINE (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo
Maria R. Gaiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment
Yujin Hoshida
PLOS ONE (2010)
The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity
Monika Pruenster et al.
NATURE IMMUNOLOGY (2009)
Differential variability analysis of gene expression and its application to human diseases
Joshua W. K. Ho et al.
BIOINFORMATICS (2008)
Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Yujin Hoshida et al.
PLOS ONE (2007)
Share Paper
